Crescent Biopharma CBIO
NASDAQ CBIO
$16.23 -1.09 (-6.29%)
At close: Aug 20, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) FCF Margin (QoQ) (2013 - 2021)

Crescent Biopharma (CBIO) FCF Margin (QoQ) (2013 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Crescent Biopharma 1.05 Bn 875.92 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 -5.31 Mn
Sep 30, 2021 956.95 Mn
Jun 30, 2021 -958.78 Mn
Mar 31, 2021 462,953.00
Dec 31, 2020 -481,539.00
Dec 31, 2015 -5.79 Mn
Sep 30, 2015 3.82 Mn
Dec 31, 2013 -68,394.00
Sep 30, 2013 -156,238.00
Jun 30, 2013 -485,728.00